ECCO'25 Abstracts

ECCO'25 Abstracts on the JCC Website

ECCO'25 Abstract Book PDF Version

ECCO'25 Abstracts COI Disclosure

ECCO'24 Abstracts

ECCO'24 Abstracts on the JCC Website

ECCO'24 Abstract Book PDF Version

ECCO'24 Abstracts COI Disclosure

Poster presentations: Clinical: Diagnosis and Outcome 2020

P115 Real-world experience of peri-operative treatments on surgical complications after Ileo-caecal resection in Crohn’s disease

P116 The occurrence of venous thromboembolisms in paediatric-onset IBD

P117 Biomarkers of extracellular matrix remodelling are associated with intestinal fibrosis assessed by magnetic resonance enterography and accumulated intestinal damage (Lémann index): the IBSEN study

P118 A comprehensive evaluation of mucosal redness in patients with ulcerative colitis by linked colour imaging

P119 Brain function and fatigue in patients with inflammatory bowel disease

P120 Prevalence of endoscopic improvement and endoscopic remission according to patient reported outcomes in ulcerative colitis

P121 Real-world use of the IBD disk tool in unselected cohorts of outpatients

P122 High correlation between faecal calprotectin and a Novel Integral Index for evaluating disease activity in ulcerative colitis patients

P123 Sarcopenia is a predictor for severe disease course in paediatric inflammatory bowel disease

P124 Clock gene expression levels can differentially distinguish between ulcerative colitis and Crohn’s disease

P125 Histological activity as a predictor of clinical outcome in ulcerative colitis: a 1-year prospective study

P126 The Urgency Numeric Rating Scale (NRS): a novel patient-reported outcome measure to assess bowel urgency in adult patients with ulcerative colitis

P128 Colorectal cancer surveillance with chromoendoscopy in inflammatory bowel disease: results from a real life experience

P129 Value of diffusion-weighted magnetic resonance enterocolonography for assessing Crohn’s disease activity

P130 Faecal calprotectin is a reliable tool to assess endoscopic activity in ulcerative colitis except for short-extent proctitis

P131 The simplified MARIA score is strongly correlated with the MARIA and Clermont scores to analyse the luminal activity of Crohn’s disease (CD) in magnetic resonance and is easier to calculate

P132 Performance of a severity score in risk stratification of patients with ulcerative colitis

P133 Pregnancy in inflammatory bowel disease: experience of a Chilean cohort

P134 Patient empowerment in inflammatory bowel disease (IBD): early education at a new diagnosis IBD clinic (NDC)

P135 Disease-related worries and concerns in UK patients with ulcerative colitis: 2-year data from ICONIC

P136 Faecal calprotectin as therapeutic target in patients with Crohn’s disease treated with anti-TNF: a meta-analysis of individual data

P137 Is there an abuse in the histological diagnosis of Crohn’s disease? (retrospective study)

P138 Basal plasma cells in normal large bowel: what is normal?

P139 Prevalence of infections in patients affected by inflammatory bowel disease treated with anti-TNF-α agents: a single-centre experience

P140 Factors associated with development of NAFLD in patients with inflammatory bowel disease: a 5-year retrospective study on 225 patients

P141 Scoring endoscopy in pediatric inflammatory bowel disease: a way to improve quality

P142 Systematic review: patient perceptions of monitoring tools in inflammatory bowel disease

P143 Gastrointestinal ultrasound is an accurate marker for endoscopic activity in Crohn’s disease

P144 Vitamin C deficiency in inflammatory bowel disease: the forgotten micronutrient

P145 Orofacial granulomatosis in Crohn’s disease: an ECCO CONFER multi-centre case series

P146 Comparison of three histologic indices in ulcerative colitis: Evaluation from the Phase 2 study of upadacitinib (U-ACHIEVE)

P147 Systematic review: diverting loop ileostomy as treatment option in severe inflammatory bowel disease

P148 Reproducibility of PICaSSO score by using narrow banding images (NBI) to assess mucosal and histological healing in ulcerative colitis (UC) patients

P149 Ulcerative colitis patients with high calprotectin levels should undergo endoscopy within 7 days for therapeutic decision

P150 Risk of hepatitis flare in patients with previous hepatitis B virus exposure amongst inflammatory bowel disease patients: results from a territory-wide Hong Kong IBD Registry study

P151 Can two different faecal calprotectin assays be used interchangeably in inflammatory bowel disease treatment?

P152 Should professionals provide their patients with digital health training resources?

P153 Fertility rate in women with IBD is decreased compared with general population: first multicentre survey in the Czech Republic

P154 Sinusitis Prompts Evaluation for Co-existing or Subsequent inflammatory bowel disease

P155 Clinical utility of fecal calprotectin in monitoring disease activity and predicting relapse in pregnant patients with inflammatory bowel diseases

P156 Interobserver variation of visual assessment vs. measuring ulcer size in Crohn’s disease using the RAPID9 Software in PillCam COLON2

P157 Patient-reported disease activity in a large sample of ulcerative colitis patients using social media-delivered questionnaires

P158 Semi-automated detection of qualitative features of Crohn’s disease activity found on CT-enterography using machine learning

P159 Histopathological findings of preclinical inflammatory bowel disease

P160 A novel PillCam Crohn’s capsule score (Eliakim score) for quantification of mucosal inflammation in Crohn’s disease

P161 Intra-abdominal abscess in Crohn’s disease

P162 Prevalence of nafld (non alcoholic fatty liver disease) and fibrosis in inflammatory bowel disease: the impact of traditional risk factors, intestinal inflammation and genetic phenotype

P163 Changes in diagnostic delay in inflammatory bowel diseases over the years: a retrospective single-centre analysis

P164 HLA G expression is differentially expressed in infiltrating cells in inflammatory bowel disease and in healthy specimens

P165 The patient’s journey: the IBD terrain

P166 Inflammatory bowel disease: risk factors to disease activity during pregnancy and postpartum

P167 Changes of diagnosis after colectomy: a single-center experience

P168 Isolated terminal ileitis: when capsule endoscopy is key for Crohn’s disease diagnosis

P169 Balloon enteroscopy in small bowel Crohn’s disease (CD) with suspected bleeding

P170 Clinical characteristics of inflammatory bowel disease associated to hydradenitis suppurativa

P171 Does microscopic involvement of the surgical margins after ileocececal resection in Crohn’s disease patients predicts early recurrence?

P172 Immunisation and vaccination status at diagnosis in Pediatric inflammatory bowel disease

P173 Very–Early-Onset inflammatory bowel disease: Russian single centre experience

P174 High frequency of fatigue and sleep alterations impact on the quality of life in Mexican patients with inflammatory bowel disease

P175 Fatty liver disease as a complication of immune-mediated inflammatory diseases: prevalence and risk factors in inflammatory bowel disease

P176 Expert consensus on acquisition and reporting of intestinal ultrasonography activity in Crohn’s disease. A prospective inter-rater agreement study

P177 Lower vedolizumab trough levels before interval shortening are not predictive of success of the intervention

P178 Variation in assessment of outcomes for inflammatory bowel disease in routine clinical practice: a mixed-methods study

P179 The acceptability and utility of United Registries for Clinical Assessment and Research (UR-CARE) database to improve clinical care in a single centre setting

P180 Association between serum and tissue protein profiles in patients with active inflammatory bowel disease: the ASCERTAIN study

P181 Triage straight to test (tSTT) improves early diagnosis of inflammatory bowel disease (IBD)

P182 Bowel Preparation in inflammatory bowel diseases (IBD): preliminary results from a randomised trial evaluating efficacy, tolerability and safety of cleansing solutions in IBD patients

P183 The prevalence of incidental terminal ileitis in persons undergoing non-diagnostic colonoscopy: a meta-analysis

P184 Temporary defunctioning ileostomy in therapy refractory Crohn’s colitis: A viable alternative to immediate colorectal resection?

P185 A comparison of early response parameters to inform a treat-to-target approach in ulcerative colitis

P186 Prevalence and management of anaemia in Greek patients with inflammatory bowel disease: a multicentre real-life cohort study

P187 The significance of netrin-1 level in the clinical activity of ulcerative colitis, its association between TNF-α and IL-6

P188 Evaluation of Global Leadership Initiative on Malnutrition (GLIM) criteria for the diagnosis of malnutrition in patients affected by inflammatory bowel disease (IBD) candidates for elective surgery

P189 Use of transabdominal ultrasonography for the evaluation of Crohn’s disease activity

P190 Systematic review: Gastrointestinal ultrasound scoring indices for inflammatory bowel disease

P191 Lower values of skeletal muscle index measured by bioelectrical impedance in active IBD patients

P192 TELEDERMA: telemedicine system for dermatological lesions in patients with inflammatory bowel disease

P193 Validation of the two-item UC patient-reported outcome (PRO2) against the simple clinical colitis activity index (SCCAI), measures of biochemical disease activity and quality of life

P194 Risk factors of axial spondyloarthritis among inflammatory bowel disease patients

P195 Cost-effectiveness of a 17-gene classifier to guide initial treatment choice in Crohn’s disease in the UK

P196 High frequency of undiagnosed mental illness in inflammatory bowel diseases

P197 A snap-shot survey of IBD patients’ at a tertiary centre: a focus on knowledge and willingness to self-manage

P198 Colorectal cancer diagnosis in patients with inflammatory bowel disease in Spain: A room for improvement

P199 Outcomes of Crohn’s rectovaginal fistulae in a specialist centre

P200 Risk of progression of preclinical ulcerative colitis

P201 Evaluating access to inflammatory bowel disease care across Canada: Proceedings from the 2017 IBD Access Summit

P202 Crohn’s disease extent and small bowel inflammatory activity: Results of a small bowel capsule endoscopy study

P203 FIT and FC as a surrogate non-invasive marker for mucosal healing in inflammatory bowel disease

P204 Re-established CRP cut-off in UC; it may be a better predictor of mucosal remission

P205 Assessing the impact of age at diagnosis on transition process in patients with inflammatory bowel diseases from paediatric to adult care

P206 Demographic data and therapy before proctocolectomy with ileal pouch-anal anastomosis are associated with long-term pouch outcomes: A report from the epi-IIRN

P207 Modelling 1-year surgery risk in Crohn’s disease: A retrospective cohort study

P208 Correlation between physician and patient disease assessments in ulcerative colitis: 2-year UK data from the ICONIC study

P209 Prospective validation of faecal calprotectin as a predictor of steroid failure in patients with acute severe colitis

P210 Clostridium difficile infection in pre-existing inflammatory bowel disease: Management and outcomes

P211 Positivity of stool sampling for enteric pathogens during inflammatory bowel disease flares in paediatric patients and its impact on disease outcomes

P212 Deep learning video analysis for a fully automated per-frame grading of ulcerative colitis

P213 Can artificial intelligence help differentiate inflammatory intestinal diseases in China? Models applying random forest and convolutional neuron network

P214 Low bone mineral density in inflammatory bowel disease patients

P215 The effect of resection margin involvement of Crohn’s disease on the surgical and clinical recurrence after intestinal surgery

P216 Anti-drug antibodies to infliximab: A comparison of free anti-drug antibody measurement

P217 The role of 7-alfa-hydroxy-4-cholesten-3-one (C4) as a biomarker for bile acid malabsorption in inflammatory bowel disease and microscopic colitis

P218 Linked colour imaging predicts the risk of the clinical relapse in ulcerative colitis

P219 Disease-specific avoidance is a predictor for fatigue in inflammatory bowel disease patients

P220 Predictors of prognosis after discontinuation of first-use biologics in IBD patients with at least 24 months follow-up

P221 Thromboembolic events in hospitalised patients with inflammatory bowel disease – a large tertiary hospital experience

P222 Extraintestinal manifestations in paediatric-onset inflammatory bowel disease depending on disease location and activity

P223 Oesophagal involvement is a predictor of anti-TNF treatment failure in patients with Crohn’s disease

P224 Crohn’s disease experiences among a paediatric population: A qualitative study reviewing the agreement of symptoms discussed by children and adolescents

P225 Using a standardised reporting proforma is associated with improved endoscopic assessment in UC

P226 Assessing the effectiveness of the nurse navigator role in an inflammatory bowel disease medical home: A retrospective cohort study

P227 Defining faecal calprotectin thresholds to predict endoscopic and histological healing in ulcerative colitis (UC) by using advanced optical enhancement techniques

P228 Cytomegalovirus Infection: is it a cause of flare-up in inflammatory bowel diseases?

P229 PillCamCrohn’sCapsule: the use of a panenteric capsule endoscopy in a Portuguese centre

P230 Health-related quality of life in adolescents and young adults (AYA) with inflammatory bowel disease and its correlations with demographic, clinical, laboratory and therapeutic evaluations

P231 Epidemiological profile and long-term outcomes from a large PSC-IBD cohort

P232 In suspected small bowel Crohn’s disease: Clinical impact of using capsule endoscopy to make decisions

P233 Evaluating the association between faecal calprotectin and endoscopic outcomes in ulcerative colitis using the HICKORY open-label induction cohort

P234 Frequency detectiveness of some viral infections in patients with inflammatory bowel diseases

P235 Serological biomarkers of interstitial matrix and basement membrane remodelling correlate the Modified Mayo Endoscopic Score (mMES) for ulcerative colitis

P236 Evaluation of histological inflammation by a novel image enhanced endoscopy technique, dual red imaging, in patients with ulcerative colitis: Preliminary study

P237 Annual incidence and prevalence of ulcerative colitis and Crohn’s disease from 2010 to 2017 in four Nordic countries: Results from the TRINordic study

P238 Natural history of perianal fistulizing Crohn’s disease in the Swiss IBD cohort

P239 Elderly-onset inflammatory bowel disease is associated with higher risks of infections, cancers and hospitalisation: Results from a territory-wide Hong Kong IBD registry

P240 CDEIS score of 2 is optimal cut-off associated with lower risk of disease progression in early Crohn’s disease: Data from the CALM study

P241 Early prediction of outcome in acute severe ulcerative colitis (ASC): comparison of clinical and endoscopic indices at presentation, with day 3 criteria

P242 Prior pregnancy outcome is an important determinant of subsequent pregnancy outcome in women with inflammatory bowel diseases

P243 Changes in the therapeutic management of inflammatory bowel disease in the biological era – a nationwide retrospective cohort study in three Nordic countries: Results from the TRINordic study

P244 Validation of the Red Flags index for early diagnosis of Crohn’s disease: A prospective general practitioner study

P245 Inter-rater reliability of gastrointestinal ultrasound in the assessment of disease activity in patients with inflammatory bowel disease prior to commencing medical therapy

P246 Long-term prognosis of ulcerative colitis and its temporal changes between 1986 and 2015 in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea

P247 Sex-related differences in clinical diagnosis of inflammatory bowel disease

P248 Validation of IBD-disk for the assessment of daily-life burden of patients with inflammatory bowel disease

P249 Use of a point-of-care screening tool to identify depression and anxiety in patients with inflammatory bowel disease

P250 Root cause analysis to identify missed opportunities for the diagnosis of colorectal cancer in inflammatory bowel disease

P251 Small bowel capsule endoscopy is a valuable diagnostic tool in isolated terminal ileitis

P252 The cardiovascular risk profile in patients with inflammatory bowel disease: A cross-sectional single-centre study (the CARE-IBD study)

P253 The prevalence of type 6 herpes with polyps in patients with inflammatory bowel disease

P254 Virtual chromoendoscopy with Narrow Band Imaging (NBI) for the classification of polypoid and non-polypoid lesions in ulcerative colitis: A prospective study using different endoscopic classifications

P255 Predictors of postoperative morbidity in patients with inflammatory bowel disease

P256 Anti-glycan antibody seropositivity at diagnosis does not predict future disease course in patients with Crohn’s disease

P257 Prognostic value of bowel ultrasonography for the management of Crohn’s disease

P258 Managing an ever-increasing inflammatory bowel disease helpline service

P259 Systematic review of prognostic factors affecting the acquisition of transition readiness skills in patients with inflammatory bowel disease

P260 Adaptation of TECCU App based on patients’ perceptions for telemonitoring inflammatory bowel disease: A qualitative study using focus groups

P261 Systematic review with meta-analysis: The impact of concomitant immune-mediated diseases on the disease course of inflammatory bowel disease

P262 Trends in the prevalence and severity of anaemia in paediatric patients with inflammatory bowel disease in the last decade

P263 Proximal disease extension in patients with ulcerative proctitis: Associated factors and experience of an IBD tertiary Brazilian centre

P264 Analysis of nutritional status and nutrient intake in patients with inflammatory bowel disease: a prospective, case–control study

P265 IBD′s features depending on the age group of patients and the timing of diagnosis of the disease

P266 Atopic diseases are associated with the development of inflammatory bowel diseases: A nationwide population-based study

P267 Validation of the short inflammatory bowel disease questionnaire as an outcome measure in Crohn’s disease patients

P268 Systematic review and meta-analysis: Inflammatory bowel disease (IBD) associated colonic dysplasia prognosis in the video-endoscopic era

P269 Mucosal capillary pattern recognition based on real-time computer-aided image analysis adequately detects histological remission in ulcerative colitis

P270 Ulcerative colitis disease extent and inflammatory burden assessment: DUBLIN and modified Nancy score

P271 Trends in faecal calprotectin levels during pregnancy and post-partum in healthy women

P272 Immune checkpoint inhibitor-related colitis assessment and prognosis: can inflammatory bowel disease scoring point the way?

P273 Point-of-care bowel ultrasound for detecting ileocolonic inflammation in Crohn’s disease

P274 The clinical significance of anastomotic ulcers after ileocolic resection to predict postoperative recurrence of Crohn’s disease

P275 Biological therapies for patients with Crohn’s disease: More options mean less surgical interventions

P276 Reactivation of Epstein–Barr virus and cytomegalovirus behaves differently in pathophysiology of ulcerative colitis

P277 Ileo-rectal anastomosis vs. ileoanal pouch in ulcerative colitis: clinical outcome in a real-life experience

P278 Comparison of prostaglandin E–major urinary metabolite (PGE-MUM) with faecal calprotectin and faecal immunochemical tests for determining endoscopic remission in patients with ulcerative colitis

P279 Early detection of mucinous adenocarcinoma within fistulating peri-anal Crohn’s disease

P280 Sodium picosulfate low-volume and split-dosed bowel preparation facilitates endoscopic monitoring of patients with inflammatory bowel disease

P281 A serum biomarker panel can accurately identify the presence of mucosal ulcers in patients with Crohn’s disease

P282 Early disease acceleration in patients with newly diagnosed Crohn’s disease in India and Israel: Insights from an East-West inception cohort

P283 Patient-reported symptoms over a period of 14 days reliably predict endoscopic and histological disease activity in ulcerative colitis (UC)

P284 Disentangling fibromyalgia from spondyloarthopathy in the patient with inflammatory bowel disease

P285 Is faecal immunochemical test a suitable alternative to faecal calprotectin in children?

P286 Rate of colectomy in ulcerative colitis: Results from a Spanish cohort with 15 years of follow-up

P287 Patient sex does not affect endoscopic outcomes of biologicals in patients with inflammatory bowel disease, but is possibly associated with adverse events: A systematic review

P288 Gut barrier failure biomarkers in IBD: Is there anything new beyond „The Wall’?

P289 Biological therapies and the trajectories of biopsychological factors in inflammatory bowel diseases

P290 Long-term disease outcome of ulcerative colitis (UC) in South Ostrobothnia, Finland with a follow-up time of 25 years

P291 Diagnostic utility of the neutrophil-platelet rate (NeuPla) as a marker of activity in patients with ulcerative colitis

P292 Inflammatory bowel disease and their implications in Roma ethnicity: A preliminary study

P293 Loss of response after first-line biologic therapy in patients with inflammatory bowel disease: practical approach and management

P294 Clinic features and the prognosis of colonic Crohn’s disease

P295 VALIDation of the IBD-Disk instrument for assessing disability in inflammatory bowel diseases in a population-based cohort: The VALIDate study

P296 Quality of reporting of lesions detected at surveillance colonoscopy for IBD

P297 Novel serum soluble markers of histological healing in ulcerative colitis

P298 Patient-reported outcomes: the ICHOM standard set for IBD in real-life practice helps quantify deficits in current care

P299 A prospective randomised trial comparing dye-based chromoendoscopy with electronic virtual chromoendoscopy for detection of colonic neoplastic lesions during IBD surveillance colonoscopy

P300 Colectomy and health-related quality life in children with ulcerative colitis

P301 Agreement in histologic diagnosis of preneoplastic lesions in inflammatory bowel disease: Results from a national survey in Italy

P302 Diagnostic accuracy of a serum-based biomarker panel for endoscopic activity in ulcerative colitis

P303 Role of parietal healing by ultrasound in the evolution of patients with Crohn’s disease

P304 Extranodal primary intestinal lymphoma in inflammatory bowel disease: An ECCO CONFER multi-centre case series

P305 A location-based prediction model in Crohn’s disease regarding a novel serological marker, anti-Chitinase 3-like 1 autoantibodies

P306 Frequency and structure of extra-intestinal manifestations in IBD

P307 Colorectal neoplasia risk in patients with inflammatory bowel disease and serrated lesions

P308 The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease

P309 Ferritin or transferrin saturation vs. soluble transferrin receptor for iron deficiency diagnosis in inflammatory bowel disease

P310 The efficacy of linked colour imaging, a novel endoscopic enhancement system, for diagnosing mucosal redness in ulcerative colitis patients in clinical remission

P311 Detection and characterisation of extra-intestinal manifestations of IBD in clinical office notes using natural language processing

P312 Introduction of bowel ultrasonography for follow-up of paediatric inflammatory bowel disease: A single-centre experience

P313 Time to second pouchitis episode in a Dutch academic cohort

P314 C-Reactive protein is associated with depression and anxiety in patients with inflammatory bowel disease

P315 Short-chain fatty acid profile in inflammatory bowel disease

P316 Hepatobiliary manifestations measured by vibration-controlled transient elastography in inflammatory bowel disease: A prospective hospital-based cohort study

P317 Key features of bowel ultrasonography in managing inflammatory bowel disease patients

P318 Artificial intelligence of the neural network-assistant for differential diagnosis of IBD

P319 Clinical characteristics of patients with inflammatory bowel disease and metabolic syndrome

P320 Thrombocytosis in acute inflammatory bowel disease: a useful biomarker?

P321 Prognosis of intestinal Behcet’s disease according to the Korean consensus-based diagnostic algorithm

P322 Impact of the presence of Epstein–Barr virus in intestinal mucosa of inflammatory bowel disease patients

P323 Successful validation of the quantum blue quantitative rapid test to monitor C-reactive protein in capillary blood of patients suffering from chronic inflammatory diseases

P324 Deep enteroscopy after balloon dilatation for differential diagnosis of small bowel stricture